GoldenGolden
Pfizer

Pfizer

Pfizer is an American, multinational pharmaceutical and biotechnology corporation.

Pfizer is an American, multinational pharmaceutical and biotechnology corporation. The company was founded in 1849, in New York, New York, United States.

Pfizer has the mission to fund programs that provide public benefit, advance medical care, and can improve patient outcomes. Their researchers preform 25,000 clinical tests everyday for pharmaceutical development and innovations.

Partnerships
BaseLaunch

Pfizer is a partner with the BaseLaunch startup accelerator. The BaseLaunch program receives applications in the fields of therapeutics, diagnostics, digital healthcare, healthcare services, therapeutic platforms, and medical technology.

Insilico Medicine

Insilico Medicine and Pfizer entered into a research collaboration agreement. The agreement allows Pfizer to utilize Insilico Medicine's machine learning technology and Pandomics Discovery Platform to research potential therapeutic targets for a variety of diseases.

AMRA Medical

AMRA Medical and Pfizer's partnership works to investigate body fat distribution and muscle composition in a range of diseases using the UK Biobank registry. The partnership involves the body composition analysis of 100,000 individuals.

CytoReason

Pfizer's partnership with CytoReason gives them access to CytoReason's machine learning platform for drug discovery and development.

XtalPi Inc.

XtalPi Inc. and Pfizer's research collaboration focuses on developing a hybrid physics-and artificial intelligence-powered software platform for accurate molecular modeling of small molecules. The platform is intended to advance both companies capabilities in drug design and solid-form selection.

Distributed Bio

Pfizer and Distributed Bio entered an agreement to license Distributed Bio's SuperHuman Platform to Pfizer. The SuperHuman 2.0 antibody discovery platform will allow Pfizer to utilize the antibody library for screening activities against Pfizer-selected targets.

Domain Therapeutics

Domain Therapeutics and Pfizer entered into a collaboration agreement to asses Domain Therapeutics's bioSensAll platform. The bioSensAll platform defines signaling signatures for each wild-type and mutant receptors. Pfizer aims to use the platform to assess the impact of mutations on different signaling pathways engaged by g protein-coupled receptors.

COVID-19

Pfizer announced that they have identified certain anti-viral compounds that are under development which could be effective in treating the novel coronavirus SARS-CoV-2 responsible for COVID-19. They may enter a partnership with a third party company to screen and identify potential compounds by the end of March, 2020 in order to begin testing in April, 2020.

Pfizer is partnered with BioNTech for co-development and distribution of an mRNA vaccine against SARS-CoV-2 called BNT162.

Timeline

May 4, 2021
Pfizer and BioNTech announces that they hope to file an emergency authorization request for their vaccine for children aged two to 11 in September in the United States.
May 2021
In a UK mix and match study published in the Lancet in May, 830 adults over 50 were randomised to get either the Pfizer or AstraZeneca vaccines first, then the other vaccine later.
April 21, 2021
The preliminary results of a report of 35,000 U.S. women who received either the Moderna or Pfizer shots while pregnant showed their rates of miscarriage, premature births and other complications were comparable to those observed in published reports on pregnant women before the pandemic.
February 25, 2021
Pfizer announces that it has begun studying a third dose of its Covid-19 vaccine, part of a strategy to guard against mutated versions of the coronavirus.
January 11, 2021
Today in healthcare news: EQRx has raised another $500 million, at least 50% of COVID-19 cases spread from people without symptoms, and some evidence that Pfizer's vaccine works against virus mutations.
2021
Pfizer reports its first-quarter 2021 revenues of $14.6 billion, a 42% operational growth.

The first-quarter revenues for the vaccine account for $3.5 billion of total revenues of $14.6 billion.

Although not explicitly addressed in the first-quarter announcement, the company expects the FDA to authorize the Pfizer-BioNTech COVID-19 vaccine within the week for adolescents ages 12 and older.

November 19, 2020
Pfizer and LianBio announce strategic collaboration to expand development of Novel Therapeutics in Greater China.
November 17, 2020
Pfizer launches Covid-19 vaccine delivery trial in four US states.
November 12, 2020
Commission approves contract with BioNTech-Pfizer alliance to ensure access to a potential vaccine

The European Commission approved a fourth contract with pharmaceutical companies BioNTech and Pfizer, which provides for the initial purchase of 200 million doses on behalf of all EU Member States, plus an option to request up to a further 100 million doses, to be supplied once a vaccine has proven to be safe and effective against COVID-19. Member States can decide to donate the vaccine to lower and middle-income countries or to re-direct it to other European countries.

November 9, 2020
Pfizer announces that the COVID-19 vaccine it's been developing is 90% effective in people who are not known to already have had the virus.
Page 1 of 2

Products

People

Name
Role
LinkedIn

A. Santiesteban

Employee

Abby Michaud

Employee

Abdalrahman Mekky, CMA

Employee

Abinaya A

Employee

Abiola Joseph

Employee

Abraham Svinkelstin, PMP, MS, MS, CSSGB

Employee

Adam Escalante

Employee

Adekunle Adeniran

Employee

Agnes Lei

Employee

AHMET ADIYAMAN

Employee

Aimee Greene

Employee

Aindréas MacDomhnaill

Employee

Aine Aherne

Employee

Akanqsha Shetty

Employee

Alba Hernandez

Employee

Alec Robert Gilarde

Employee

Alejandra Fonseca

Employee

Alekhya Reddy

Employee

Alex Haddad

Employee

Alexander H. Buell

Employee

Alexandra Grossbarth

Employee

Alexey Chapyshev

Employee

Alican Liceoglu

Employee

Alisha Dhiman

Employee

Alison Hanlon

Employee

Page 1 of 28
...

Further reading

Title
Author
Link
Type
Date

Our Science: Pharmaceutical Development | Pfizer | Pfizer

Web

Pfizer's Core Values of Social Responsibility and Philanthropy | Pfizer

Web

What to Know About Coronavirus -- COVID-19 Explained | Pfizer

Web

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

Pfizer

Alberta Bourla

New York, New York, United States

Medical, healthcare, biotechnology, and pharmaceutical products and services

News

Title
Author
Date
Publisher
Description
AP
June 15, 2021
HuffPost
Individuals who received doses of the Pfizer vaccine at the former NFL Experience building between June 5-10 should schedule another Pfizer shot as soon ...
Gail Dutton
June 15, 2021
BioSpace
A sense of urgency, powerful science, relentless ingenuity, hope and trust drove the development of Pfizer and BioNTech's mRNA vaccine during the height of the COVID-19 pandemic. As the crisis appears to lessen, Pfizer is preparing for the next pandemic.
June 15, 2021
The Indian Express
Researchers at Public Health Scotland and the University of Edinburgh, UK, found that the Pfizer-BioNTech vaccine offered better protection against the Delta variant compared to the Oxford-AstraZeneca preventive, known as Covishield in India.
BioSpace
June 15, 2021
BioSpace
Acticor Biotech today announced appointment of Mr Alain Munoz as Chairman of the Board of Directors and Mrs Sophie Binay and Mr Yannick Pletan as General Managers.
IANS
June 15, 2021
@bsindia
The analysis suggests that the Pfizer-BioNTech vaccine is 96 per cent effective against hospitalisation after two doses
Telegraph reporters
June 15, 2021
The Telegraph
Those in their mid-to-late 20s are now being invited to receive a vaccine, with over 29 million people now fully inoculated
June 14, 2021
News-Medical.net
A reassuring study, released as a preprint on the medRxiv* server, from a multi-institutional team of researchers in Italy suggests that with the Pfizer-BioNTech BNT162b2 vaccine, post-vaccination immunity against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is both robust and durable.
Neetu Chandra Sharma
June 14, 2021
mint
Even though many countries have begun pregnant women's covid-19 vaccination, the Indian government has so far been conservative citing lack of clinical trial data
Telegraph reporters
June 14, 2021
The Telegraph
Those in their late 20s are now being invited to receive a vaccine, with over 29 million people now fully inoculated
June 13, 2021
The Indian Express
A U.S. initiative announced on Thursday to donate 500 million doses of the Pfizer and BioNTech SE vaccine is part of the G7 pledge.
June 11, 2021
IndiaTimes
Indiatimes.com brings you the news, articles, stories and videos on entertainment, latest lifestyle, culture & new technologies emerging worldwide.
Press Trust of India
June 12, 2021
@bsindia
Successful variants often have a biological advantage -- through mutation -- that helps them spread more easily among the population
Laura Ramirez-Feldman
June 11, 2021
news.google.com
Now that almost half the U.S. population is fully vaccinated against COVID-19, many people are beginning to wonder how long that protection will last, and if...
June 11, 2021
cnbctv18.com
The CDC's vaccine advisory committee will meet on June 18 to further evaluate the possible risk.Get latest Healthcare online at cnbctv18.com
June 11, 2021
Jammu Kashmir Latest News | Tourism | Breaking News J&K
Washington, Jun 11:US health officials are investigating what appear to be higher than expected reports of heart inflammation in male teens and young
Telegraph reporters
June 11, 2021
The Telegraph
Those in their late 20s are now being invited to receive a vaccine, with over 28 million people now fully inoculated
Lila Seidman
June 10, 2021
Los Angeles Times
The COVID-19 vaccine could be approved for children in the age group by fall, if the trial in Northern California goes well, a Kaiser official said.
Research and Markets
June 10, 2021
www.prnewswire.com:443
/PRNewswire/ -- The "Global Injectable Drugs Market (2021 Edition) - Analysis By Molecule (Small, Large), Delivery (Prefilled, Infusion, Others), Product, By...
June 10, 2021
BioSpace
NiKang Therapeutics Appoints Robert Xin, M.D., Ph.D., as Chief Medical Officer - read this article along with other careers information, tips and advice on BioSpace
BioSpace
June 10, 2021
BioSpace
ACELYRIN, INC. today announced the appointment of Patrick (Pat) Machado , JD to its board of directors.
SHOW MORE

References

Page 1 of 3
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.